Literature DB >> 31445732

Rapid Response to Pembrolizumab in a Critically Ill Mechanically Ventilated Patient with New Diagnosis of NSCLC.

Erin M McLoughlin1, James M Larner2, Michael P Bergman3, Edward B Stelow4, Kevin Brady5, Alia C Lynch5, Ralph S Abraham6, Ryan D Gentzler7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31445732     DOI： 10.1016/j.jtho.2019.04.010

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients.

Authors:  Valérie Gounant; Michael Duruisseaux; Ghassen Soussi; Sylvie Van Hulst; Olivier Bylicki; Jacques Cadranel; Marie Wislez; Jean Trédaniel; Jean-Philippe Spano; Carole Helissey; Christos Chouaid; Olivier Molinier; Xavier Dhalluin; Ludovic Doucet; José Hureaux; Aurélie Cazes; Gérard Zalcman
Journal:  Cancers (Basel)       Date:  2021-03-02       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.